User contributions
Jump to navigation
Jump to search
- 01:56, 16 December 2021 diff hist -4 m Upper tract urothelial carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:56, 16 December 2021 diff hist -22 m Breast cancer, HER2-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:54, 16 December 2021 diff hist -24 m Graft versus host disease Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:53, 16 December 2021 diff hist -90 m Colon cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:53, 16 December 2021 diff hist -6 m Non-small cell lung cancer, ALK-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:51, 16 December 2021 diff hist -4 m Chronic lymphocytic leukemia - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:51, 16 December 2021 diff hist -48 m Hepatocellular carcinoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:51, 16 December 2021 diff hist -28 m Gallbladder cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:51, 16 December 2021 diff hist -2 m Heparin-induced thrombocytopenia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:50, 16 December 2021 diff hist -12 m Waldenström macroglobulinemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:50, 16 December 2021 diff hist -166 m Small cell lung cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:49, 16 December 2021 diff hist -2 m Neuroendocrine tumor Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:48, 16 December 2021 diff hist -2 m Hypereosinophilic syndrome Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:48, 16 December 2021 diff hist -62 m Non-small cell lung cancer, squamous Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:48, 16 December 2021 diff hist -78 m Esophageal cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:48, 16 December 2021 diff hist -20 m Light-chain (AL) amyloidosis Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:47, 16 December 2021 diff hist -30 m Autologous HSCT Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:47, 16 December 2021 diff hist -8 m Thyroid cancer, medullary Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:46, 16 December 2021 diff hist -46 m Testicular cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:45, 16 December 2021 diff hist -30 m Bladder cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:45, 16 December 2021 diff hist -144 m Diffuse large B-cell lymphoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:45, 16 December 2021 diff hist -26 m Malignant pleural mesothelioma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:45, 16 December 2021 diff hist -4 m Classical Hodgkin lymphoma, pediatric Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:45, 16 December 2021 diff hist -20 m Acute myeloid leukemia, FLT3-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:44, 16 December 2021 diff hist -26 m Breast cancer, HER2-positive - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:44, 16 December 2021 diff hist -8 m Acquired thrombotic thrombocytopenic purpura Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:42, 16 December 2021 diff hist -4 m Non-small cell lung cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:42, 16 December 2021 diff hist -38 m Cholangiocarcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:42, 16 December 2021 diff hist -4 m Polycythemia vera Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:42, 16 December 2021 diff hist -12 m Gastrointestinal stromal tumor - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:40, 16 December 2021 diff hist -2 m High-grade glioma, pediatric Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:40, 16 December 2021 diff hist -2 m Uveal melanoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:40, 16 December 2021 diff hist -8 m Follicular lymphoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:39, 16 December 2021 diff hist -66 m Colon cancer, RAS wild-type Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:39, 16 December 2021 diff hist -6 m Cutaneous T-cell lymphoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:39, 16 December 2021 diff hist -4 m Ovarian cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:39, 16 December 2021 diff hist -604 m Colon cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:39, 16 December 2021 diff hist -54 m Acute myeloid leukemia - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:38, 16 December 2021 diff hist -10 m Multiple myeloma, relapsed-refractory Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:38, 16 December 2021 diff hist -54 m Gastric cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:38, 16 December 2021 diff hist -26 m Diffuse large B-cell lymphoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:38, 16 December 2021 diff hist -6 m Nasopharyngeal carcinoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:38, 16 December 2021 diff hist -472 m Breast cancer, ER-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:37, 16 December 2021 diff hist -12 m Colorectal cancer, MSI-H or dMMR Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:37, 16 December 2021 diff hist -4 m Neuroblastoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:37, 16 December 2021 diff hist -14 m Cervical cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:37, 16 December 2021 diff hist -2 m Urothelial carcinoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:34, 16 December 2021 diff hist 0 m Editing test page 2 Text replacement - "edit after update" to "replace text test"
- 15:19, 28 October 2021 diff hist -5 m Editorial Board Nikki Wood user link
- 04:16, 20 September 2021 diff hist +1 m Acalabrutinib (Calquence) Text replacement - "[[File:" to "[[:File:"